Late Noncardiac Surgery in Heart Transplant Patients

详细信息    查看全文

• 作者：R. Marzoa ; M.G. Crespo-Leiro ; M.J. Paniagua ; I. Bendayá ; n ; R. Rios ; R. Franco ; J.A. Rodriguez ; E. Barge ; C. Naya ; M. Gó ; mez ; J.J. Cuenca ; A. Juffé ; ; A. Castro-Beiras
• 关键词：Blood transfusion ; Evaluation of the professional practices ; Continuous medical training
• 刊名：Transplantation Proceedings
• 出版年：2007
• 出版时间：September 2007
• 年：2007
• 卷：39
• 期：7
• 页码：2382-2384
• 全文大小：58 K

文摘

Because of improved long-term survival of heart transplants (HT), patients often need noncardiac surgery (NCS). Immunosuppression may increase the infection rate. Inadequate management may increase the risk of dysfunction or acute rejection episodes (ARE). Long-term outcomes of NCS and optimal immunosuppressive management in the perioperative period are not well known. The objective of this study was to analyze the incidence, morbidity, and mortality of late NCS after HT.

Methods

We retrospectively evaluated the incidence and type of late NCS as well as the risk factors for complications and the mortality among 207 HT patients. Immunosuppression and ARE rates were also analyzed.

Results

One hundred and sixteen late NCS (84.5 % elective) were performed in 72 HT patients (34.8 % ). Interventions were: 35 urologic (30.2 % ), 29 abdominal (25 % ), 14 vascular (12.1 % ), 13 ENT (11.2 % ), 11 skin and soft tissue (9.5 % ), and 7 orthopedic (6 % ). Malignancy was the main indication for NCS (33.6 % ). Only 4 patients (5.6 % ) died preoperatively. Mortality was higher among emergent vs elective procedures (16.6 % vs 1 % ; P = .012) and among patients with preoperative high vs middle/low risk (26.6 % vs 0 % ). Postsurgical infection was the most frequent complication (6.9 % ). However, there were no relevant complications in 82.8 % of HT patients. Hospitalization time was <15 days in two thirds of patients. Immunosuppression was modified in 33 patients (28.4 % ), especially when the surgical indication was neoplasia (P < .001). None of the patients with NCS displayed allograft dysfunction or an ARE.

Conclusions

More than one-third of HT patients needed a late NCS. In our experience, elective surgical procedures with middle/low preoperative cardiovascular risk are safe. In this context, the risk of rejection was low when immunosuppression was carefully monitored to reduce the risk of infection.